Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.

Inclusion Criteria

• •1. Men and women, 18-75 years of age;
• •2. Participant with a histologically or cytologically confirmed solid tumor receiving treatment with chemotherapeutic agents;
• •3. Participant experienced thrombocytopenia and chemotherapy delay;
• •4. ECOG performance status 0-1;
• •5. Adequate Liver function; aspartate aminotransferase (AST) and alanine aminotransferase (ALT) \< 3.0 x ULN for participants without liver metastases or 5.0 x ULN for participant with liver metastases);
• •6. Adequate renal function; serum creatinine \< 1.5 x ULN or eGFR≤60 ml/min（Cockcroft-Gault）